A Phase II Clinical Trial of Celecoxib Combined with Platinum-Based Regimen as First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients with Cyclooxygenase-2 Positive Expression
Cancer Patients、Clinical Trial、gene amplification、survival time、survival rate、response rate、growth factor receptor、predictive factors、molecular analysis、prognostic factor、overall survival、disease control、model analysis、lung cancer
21
R734.2(肿瘤学)
the grants from the National High Technology Research and Development Program of China 863 Program2006AA02A401;the Capital Development Foundation30772472;Peking University 985 Program2-013-39
2009-04-03(万方平台首次上网日期,不代表论文的发表时间)
共12页
1-12